IL6 and breast cancer: Remarkably, COX-2 has been shown to promote metastatic potential of breast cancer cells in TAMs [42], while IL-6 signaling is assumed to contribute to a pro-tumor condition by supporting angiogenesis and tumor elusion of immune surveillance [33,34].